Cancer as a metabolic disease: implications for novel therapeutics.
Cancer as a metabolic disease: implications for novel therapeutics.
复制标题
DOI:
10.1093/carcin/bgt480
复制
发表时间:
2014-03
期刊:
影响因子:
4.7
通讯作者:
D'Agostino DP
中科院分区:
文献类型:
--
作者:
Seyfried TN;Flores RE;Poff AM;D'Agostino DP
Emerging evidence indicates that cancer is primarily a metabolic disease involving disturbances in energy production through respiration and fermentation. The genomic instability observed in tumor cells and all other recognized hallmarks of cancer are considered downstream epiphenomena of the initial disturbance of cellular energy metabolism. The disturbances in tumor cell energy metabolism can be linked to abnormalities in the structure and function of the mitochondria. When viewed as a mitochondrial metabolic disease, the evolutionary theory of Lamarck can better explain cancer progression than can the evolutionary theory of Darwin. Cancer growth and progression can be managed following a whole body transition from fermentable metabolites, primarily glucose and glutamine, to respiratory metabolites, primarily ketone bodies. As each individual is a unique metabolic entity, personalization of metabolic therapy as a broad-based cancer treatment strategy will require fine-tuning to match the therapy to an individual’s unique physiology.
登录
查看更多内容
影响因子:
3.8
作者:
Baker, Stuart G.;Kramer, Barnett S.
通讯作者:
Kramer, Barnett S.
影响因子:
4.3
作者:
Bonuccelli, Gloria;Tsirigos, Aristotelis;Lisanti, Michael P.
通讯作者:
Lisanti, Michael P.
影响因子:
5.4
作者:
Bozidis, Petros;Williamson, Chad D.;Colberg-Poley, Anamaris M.
通讯作者:
Colberg-Poley, Anamaris M.
DOI:
10.1126/science.1226683
发表时间:
2012-12-07
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Al Mamun AA;Lombardo MJ;Shee C;Lisewski AM;Gonzalez C;Lin D;Nehring RB;Saint-Ruf C;Gibson JL;Frisch RL;Lichtarge O;Hastings PJ;Rosenberg SM
通讯作者:
Rosenberg SM
影响因子:
4.3
作者:
Baracca, Alessandra;Chiaradonna, Ferdinando;Lenaz, Giorgio
通讯作者:
Lenaz, Giorgio